Lobbying Information
Subject Matters
- Consumer Issues
- Government Procurement
- Health
- Industry
- Intellectual Property
- International Relations
- International Trade
- Regional Development
- Research and Development
- Science and Technology
- Taxation and Finance
Subject Matter Details
Grant, Contribution or Other Financial Benefit
- National Immunization Strategy. Advocacy to seek continued funding in vaccines.
Legislative Proposal, Bill or Resolution, Regulation
- Patent Act as it relates to the implementation of the Comprehensive Economic Trade Agreement (CETA) and its Intellectual property protection provisions.
- The international trade negotiations under the Tans-Pacific Partnership (TPP) as it relates to potential legislative or regulatory changes of Canada's intellectual property regime for pharmaceutical products (Patent Act).
Policies or Program
- Canadian Agency for Drugs and Technologies in Health (CADTH)/Common Drug Review as it relates to reimbursement recommendations decision-making process and framework.
- Federal Public Drug Plans, with respect to the reimbursement of therapeutic products for Federal plan beneficiaries
- Science and Technology Strategy, Advantage Canada or any Government policy or program initiatives to help support more Research and Development conducted in Canada, advocate for the development of a coordinated life science strategy
Policies or Program, Regulation
- Subsequent Entry Biologics (SEBs) and Orphan Drugs framework: seeking an approval framework supported and protected by Regulations in harmonization with other developed countries
Regulation
- Patented Medicine Prices Review Board (PMPRB) Regulations as it relates to reporting requirements and pricing guidelines.
- Patented Medicines (Notice of Compliance) Regulations as it relates to the regulation of intellectual property for therapeutic products.
- The implementation of all the upcoming regulations related to Bill C-17, formerly known as an Act to Amend the Food and Drugs Act
Communication Techniques
-
Written communication
-
Grass-roots communication
-
As part of Industry Associations and Delegations eg. Rx&D, BIOTECanada, Chamber of Commerce
Government Institutions
-
Atlantic Canada Opportunities Agency (ACOA)
-
Canada Economic Development for Quebec Regions
-
Canada Revenue Agency (CRA)
-
Canadian Institutes of Health Research (CIHR)
-
Employment and Social Development Canada (ESDC)
-
Federal Office of Regional Development – Quebec (FORD[Q])
-
Finance Canada (FIN)
-
Global Affairs Canada (GAC)
-
Health Canada (HC)
-
House of Commons
-
Indigenous and Northern Affairs Canada
-
Innovation, Science and Economic Development Canada (ISED)
-
Justice Canada (JC)
-
Members of the House of Commons
-
National Defence (DND)
-
Patented Medicine Prices Review Board (PMPRB)
-
Prime Minister's Office (PMO)
-
Privy Council Office (PCO)
-
Public Health Agency of Canada (PHAC)
-
Public Services and Procurement Canada (PSPC)
-
Revenue Canada (RC)
-
Senate of Canada
-
Treasury Board Of Canada Secretariat (TBS)
-
Veterans Affairs Canada (VAC)
-
Western Economic Diversification Canada (WD)
In-house Corporation Details
Description of activities
Pfizer's mission is to discover and develop innovative medicines, vaccines and other products to improve the quality of life of people and animals.
Responsible officer name and position during the period of this registration
John Helou,
Président et chef de la direction
Government funding
No government funding was received during the last completed financial year.
In-house Corporation Contact Information
Address:
17,300 TRANS-CANADA HIGHWAY
KIRKLAND, QC H9J 2M5
Canada
Telephone number:
514-693-4563
Fax number:
514-426-6921
Parent Company Information
- PFIZER INC
-
235 EAST 42ND STREET
NEW YORK, NY 10017-5755
United States of America
Subsidiary Beneficiary Information
Pfizer Canada ULC does not have any subsidiaries that could have a direct interest in the outcome of the undertaking
Lobbyists Details
Senior Officers whose lobbying activities represent less than 20% of their Duties
- Denise Cloutier,
National Director, Health & Economic Policy |
No public offices held
- John Helou,
Président et chef de la direction |
No public offices held
Senior Officers and Employees whose lobbying activities represent 20% or more of their Duties